Jolein Pleijster
Overview
Explore the profile of Jolein Pleijster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Juliana N, Omar A, Pleijster J, Aftab F, Uijldert N, Ali S, et al.
Microorganisms
. 2021 Jun;
9(6).
PMID: 34070767
This study aimed to determine the persistence of (CT), (NG), (TV) and (MG) infections during pregnancy and after delivery in vaginal swabs of women from Pemba Island, Tanzania. In the...
2.
Juliana N, Deb S, Ouburg S, Chauhan A, Pleijster J, Ali S, et al.
Pathogens
. 2020 Aug;
9(8).
PMID: 32751883
Efforts to map the burden of infections globally have shown a high prevalence of genital infections, including , in sub-Saharan Africa. This retrospective study aimed to investigate the prevalence of...
3.
Hoenderboom B, van Willige M, Land J, Pleijster J, Gotz H, van Bergen J, et al.
Microorganisms
. 2019 Oct;
7(10).
PMID: 31614620
The asymptomatic course of (CT) infections can result in underestimated CT lifetime prevalence. Antibody testing might improve this estimate. We assessed CT antibody positivity and predictive factors thereof in the...
4.
Lanjouw E, Brankovic I, Pleijster J, Spaargaren J, Hoebe C, van Kranen H, et al.
Pathog Dis
. 2016 Feb;
74(3).
PMID: 26867646
Chlamydia trachomatis is the most common sexually transmitted bacterium worldwide. Its often asymptomatic course of infection increases chances of transmission, and increases risk of late complications. Genetic variations in the...
5.
Verweij S, Karimi O, Pleijster J, Lyons J, de Vries H, Land J, et al.
Pathog Dis
. 2015 Nov;
74(1):ftv107.
PMID: 26568059
Chlamydia trachomatis infections demonstrate remarkable differences in clinical course that are approximately 40% based on host genetic variation. Here, we study the single nucleotide polymorphisms (SNPs) and their haplotypes in...
6.
Verweij S, Lanjouw E, Bax C, Quint K, Oostvogel P, Dorr P, et al.
BMC Infect Dis
. 2014 Jan;
14:3.
PMID: 24383586
Background: Chlamydia trachomatis is the most prevalent bacterial sexually transmitted infection (STI) worldwide. A strong link between C. trachomatis serogroup/serovar and serological response has been suggested in a previous preliminary...
7.
Jiang J, Karimi O, Ouburg S, Champion C, Khurana A, Liu G, et al.
PLoS One
. 2012 Nov;
7(11):e47487.
PMID: 23189125
Background: Regulation of immune responses is critical for controlling inflammation and disruption of this process can lead to tissue damage. We reported that CXCL13 was induced in fallopian tube tissue...
8.
de Vries H, Smelov V, Ouburg S, Pleijster J, Geskus R, Speksnijder A, et al.
Sex Transm Dis
. 2010 Jul;
37(12):789-95.
PMID: 20625350
Background: Anal lymphogranuloma venereum (LGV) infections, caused by Chlamydia trachomatis biovar L (Ct+/LGV+), are endemic among men who have sex with men (MSM). Anal non-LGV biovar Ct infections (Ct+/LGV-) can...
9.
de Vries H, Smelov V, Middelburg J, Pleijster J, Speksnijder A, Morre S
Clin Infect Dis
. 2009 Feb;
48(5):e53-6.
PMID: 19191633
Microbial cure of chlamydia proctitis (lymphogranuloma venereum [LGV] and non-LGV) with doxycycline treatment was evaluated by chlamydia DNA and RNA persistence in anal swab specimens. In LGV proctitis, RNA persisted...
10.
Ouburg S, Spaargaren J, den Hartog J, Land J, Fennema J, Pleijster J, et al.
BMC Infect Dis
. 2005 Dec;
5:114.
PMID: 16368002
Background: The functional polymorphism -260 C>T in the LPS sensing TLR4 co-receptor CD14 gene enhances the transcriptional activity and results in a higher CD14 receptor density. Individuals carrying the T/T...